BRCA1 and breast neoplasm: Increased PD-L1 expression is identified in breast tumors deficient in DNA repair, and infiltrating immune-cell PD-1 and PD-L1 expression is higher in breast cancers with BRCA1 or BRCA2 mutations [90, 147].